FineMark National Bank & Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-211	Closed	-$222K	–	453
2024 Q3	$222K	Hold	211	–	–	0.01%	395
2024 Q2	$222K	Hold	211	–	–	0.01%	385
2024 Q1	$203K	Buy	+211	New	+$201K	0.01%	406
2023 Q3	–	Sell	-487	Closed	-$350K	–	429
2023 Q2	$350K	Buy	+487	New	+$375K	0.01%	321
2017 Q1	–	Sell	-220	Closed	-$81K	–	856
2016 Q4	$81K	Hold	220	–	–	0.01%	523
2016 Q3	$89K	Buy	220 +153	+228%	+$61.4K	0.01%	487
2016 Q2	$23K	Sell	67 -44	-40%	-$16.9K	﹤0.01%	800
2016 Q1	$40K	Sell	111 -104	-48%	-$42.9K	﹤0.01%	629
2015 Q4	$117K	Buy	215 +2	+0.9%	+$1.08K	0.01%	419
2015 Q3	$99K	Sell	213 -84	-28%	-$45.1K	0.01%	459
2015 Q2	$151K	Sell	297 -64	-18%	-$31.2K	0.02%	388
2015 Q1	$163K	Sell	361 -14	-4%	-$5.93K	0.02%	383
2014 Q4	$154K	Sell	375 -6	-2%	-$2.36K	0.02%	401
2014 Q3	$138K	Buy	381 +195	+105%	+$65.4K	0.02%	397
2014 Q2	$52K	Buy	186 +13	+8%	+$3.85K	0.01%	624
2014 Q1	$52K	Buy	173 +26	+18%	+$8.01K	0.01%	598
2013 Q4	$40K	Buy	147 +4	+3%	+$1.15K	0.01%	630
2013 Q3	$45K	Buy	+143	New	+$37.6K	0.01%	594